Wetsvoorstel implementatie richtlijn 2012/28/EU inzake verweesde werken

This legislative proposal aims to implement EU Directive 2012/28/EU into Dutch national law. The directive establishes incentives for the development of medicines intended for the treatment of rare diseases, known as orphan medicinal products, to ensure these treatments become commercially viable. Pharmaceutical companies and patients with rare diseases are primarily affected. The law ensures that developers receive specific protections and incentives, facilitating the availability of specialized medicines in the Netherlands.